Search Within

Leonard B Saltz

Formats
  1. Journal Article (484)
  2. Meeting Abstract (254)
  3. Book Section (24)
  4. Guidelines (12)
  5. Editorial (8)
  6. Correspondence (5)
  7. Review (4)
  8. Book Whole (2)
  9. Conference Paper (2)
  10. Research Letter (1)
Groups
  1. Department of Medicine (796)
  2. Gastrointestinal Oncology Service (796)
  3. Solid Tumor Oncology Division (796)
  4. Center for Pancreatic Cancer Research (309)
  5. Surgery (236)
  6. Survivorship Research (232)

More Groups

People
  1. Martin Weiser (133)
  2. Andrea Cercek Hanjis (127)
  3. Philip Paty (122)
  4. Jinru Shia (101)
  5. Nancy Kemeny (98)
  6. Jose Guillem (89)

More People

Years
  1. 2025 (16)
  2. 2024 (21)
  3. 2023 (24)
  4. 2022 (22)
  5. 2021 (18)
  6. 2020 (30)

More Years

Publications
  1. Journal of Clinical Oncology (271)
  2. Journal of the National Comprehensive Cancer Network (42)
  3. Annals of Oncology (36)
  4. Cancer (31)
  5. Clinical Cancer Research (27)
  6. Annals of Surgical Oncology (26)

More Publications

Publishers
  1. American Society of Clinical Oncology (287)
  2. Oxford University Press (82)
  3. Elsevier Inc. (73)
  4. Springer (49)
  5. Harborside Press (42)
  6. American Association for Cancer Research (41)

More Publishers

Results (796)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ACR Appropriateness Criteria on resectable rectal cancer. Expert panel on radiation oncology-rectal/anal cancer
    Journal Article

    Suh, W. W.; Blackstock, A. W.; Herman, J.; Konski, A. A.; Mohiuddin, M.; Poggi, M. M.; Regine, W. F.; Cosman, B. C.; Saltz, L.; Johnstone, P. A. S.
    International Journal of Radiation Oncology, Biology, Physics (2008)

    Fulltext@MSK | Save
  • Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
    Journal Article

    Shia, J.; Tang, L. H.; Weiser, M. R.; Brenner, B.; Adsay, N. V.; Stelow, E. B.; Saltz, L. B.; Qin, J.; Landmann, R.; Leonard, G. D.; more...
    American Journal of Surgical Pathology (2008)

    Fulltext@MSK | Save
  • Is adjuvant therapy for stage II colon cancer worthwhile, and for whom? Commentary
    Journal Article

    Segal, N. H.; Saltz, L. B.
    Nature Clinical Practice Gastroenterology & Hepatology (2008)

    Fulltext@MSK | Save
  • Bevacizumab: One treatment for all the seasons? - Reply
    Journal Article

    Saltz, L. B.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized phase III study
    Journal Article

    Saltz, L. B.; Clarke, S.; Díaz-Rubio, E.; Scheithauer, W.; Figer, A.; Wong, R.; Koski, S.; Lichinitser, M.; Yang, T. S.; Rivera, F.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Biomarkers in colorectal cancer: Added value or just added expense?
    Journal Article

    Saltz, L. B.
    Expert Review of Molecular Diagnostics (2008)

    Fulltext@MSK | Save
  • Management of metastatic colorectal cancer: The impact of clinical trials reported at ASCO 2007
    Journal Article

    Saltz, L.
    Community Oncology (2008)

    Fulltext@MSK | Save
  • Progress in cancer care: The hope, the hype, and the gap between reality and perception
    Journal Article

    Saltz, L. B.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Bevacizumab in advanced colorectal cancer: A challenge to the current paradigm - Reply
    Journal Article

    Saltz, L.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation
    Journal Article

    Quah, H. M.; Chou, J. F.; Gonen, M.; Shia, J.; Schrag, D.; Saltz, L. B.; Goodman, K. A.; Minsky, B. D.; Wong, W. D.; Weiser, M. R.
    Cancer (2008)

    Fulltext@MSK | Save